AUSTIN, Texas--(BUSINESS WIRE)--Astrotech (NASDAQ: ASTC) will demonstrate 1st Detect’s mass spectrometry-based explosives and narcotics detector, the TRACER 1000, at Stand 529 at the Border Security Expo (BSE) in San Antonio, TX from Jan. 31st to Feb. 2nd, 2018.
“With high-level decision makers from throughout the world in attendance, the Border Security Expo is an excellent venue to showcase the TRACER 1000 to our target audience of government, border, immigration and law enforcement agencies,” said Thomas B. Pickens III, CEO of 1st Detect and Astrotech. “We look forward to arming security forces worldwide with our advanced technologies, both to help combat the opioid epidemic and keep borders safe from terroristic threats.”
Critical for operators at all levels of leadership as well as industry partners, BSE provides a comprehensive understanding of the challenges of the border environment, and the opportunity to be an integral part of identifying workable solutions. For more information, visit www.bordersecurityexpo.com.
Astrotech is an innovative science and technology company that invents, acquires, and commercializes technological innovations sourced from research institutions, laboratories and internally–then funds, manages, and builds scalable start-up companies for profitable divestiture to market leaders to maximize shareholder value. 1st Detect develops and sells chemical analyzers for use in the security, defense, healthcare and environmental markets. Astrotech is headquartered in Austin, Texas. For more information, visit www.1stdetect.com or www.astrotechcorp.com.
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, whether we can successfully develop our proprietary technologies and whether the market will accept our products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.